Collate is building an AI-native enterprise platform aimed at automating and streamlining documentation for the life sciences sector. The company, founded in 2025, focuses on serving drug development, medical devices, and diagnostics companies. Its technology addresses a critical bottleneck in regulated industries where documentation spans R&D, clinical trials, marketing, and sales.
The platform applies artificial intelligence to enterprise software challenges specific to life sciences, where compliance-heavy documentation processes are traditionally manual and time-consuming. By targeting this niche at the intersection of AI and regulated industry workflows, Collate positions itself within a growing market for vertical AI solutions.
The company's stated motivation is speed to market for patient-facing products. Its operating ethos, captured in the motto "patients are waiting," reflects an urgency-driven culture oriented toward reducing the time between scientific development and commercial availability.
